Back to search results
NCT05066711

NuVasive® ACP System Study

Enrolling by Invitation
Not specifiedAges 18+Observational
NuVasive
~75 participants
Updated 2025-12-22 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Complications NuVasive ACP System
Measured over 24 months
+1 more outcome measured

Conditions

Cervical Spondylosis
Cervical Radiculopathy
Cervical Myelopathy
Cervical Disc Disease
Cervical Stenosis
Cervical Disc Herniation
Cervical Spine Disease

Explore related trials

Cervical disc disorderCervical myelopathyCervical radiculopathyCervical spine deformityCervical Spine TumorCervical spondylosisFailed Cervical FusionPlunging ranulaProlapsed cervical intervertebral discSpinal stenosis in cervical region

Where it's being run

3 sites across 3 states
Illinois1
Missouri1
North Carolina1

Study leadership

  • Kyle Malone, MS · STUDY_DIRECTOR · Globus Medical Inc

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

What this trial measures

  • Complications NuVasive ACP System24 months

    Rate of complications (i.e., safety) attributable to use of the NuVasive ACP System

  • Radiographic Success24 months

    Proportion of subjects with radiographic success at: 1. Latest time point available for patients undergoing surgery to treat advanced stage tumors 2. 24 months postoperative for subjects undergoing surgery to treat instabilities, traumatic spinal fractures, failed previous fusions, or degenerative disease